Clinical trial
Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel Using the Bat 24 Regimen Versus Daily and Pericoital Dosing
NCT01369303 is registered in ClinicalTrials.gov with CONRAD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel Using the Bat 24 Regimen Versus Daily and Pericoital Dosing
- Lead sponsor
- CONRAD
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- May 31, 2013
- Enrollment
- 194 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
prevention